Order number: 341X.1
Part number: AC100008825
Formulated to support synthetic operations, the Hplc Column Nucleodur® C 8 Gravity, 1.8 μm, 100 mm, 4.6 mm offers an ideal solution for reversed phase (RP) separations. Its base deactivated (BDS), high density monomeric octyl (C 8 , MOS) modification ensures hydrophobic (van der Waals) interactions, making it suitable for the separation of basic and other ionizable analytes. With a particle size of 1.8 μm, this UHPLC column delivers exceptional pressure stability up to 900 bar and temperature stability up to 60°C. The column's specific surface area of 340 m²/g, combined with its pH stability range of 1-11, makes it a versatile tool for various applications, including pharmaceuticals
| Name | Value | |
|---|---|---|
| Phase | : | C 8 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | UHPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L7 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 1.65 ml |
| Particle size | : | 1.8 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8 |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification |
| Pressure stability | : | 900 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 100 x 4.6 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
© 2026 Copyright. All Rights Reserved.
© 2026 Copyright. All Rights Reserved.